Last $48.70 USD
Change Today +1.07 / 2.25%
Volume 836.6K
INCY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard U. De Schutter

Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Finance Committee, Incyte Corporation
AgeTotal Calculated CompensationThis person is connected to 52 board members in 9 different organizations across 17 different industries.

See Board Relationships
73$323,648

Background*

Mr. Richard U. De Schutter has been the President of L.B. Gemini, Inc. since 2000. Mr. De Schutter served as an Operating Partner of Linden LLC. He served as Executive Chairman, Chief Executive Officer and President of DuPont Pharmaceutical Company from 2000 to December 2001. He joined DuPont Pharmaceutical Company in 2000. From January 1999 to March 2000, he served as the Chief Administration Officer of Monsanto Company, where he served for 35 years. He served as the ...

Read Full Background

Corporate Headquarters*

Experimental Station
Wilmington, Delaware 19880

United States

Phone: 302-498-6700
Fax: --

Board Members Memberships*

Prior
Former Director
Independent Director, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee
Chairman, President, and Chief Executive Officer
Former Chairman and Chief Executive Officer
Former Chairman of the Board
Former Director
Director and Chairman of Organization & Compensation Committee
Director
Director
1997-2004
Former Director
1999-N/A
Former Vice Chairman, Chief Administrative Officer, Chairman of G D Searle & Co, Chief Executive Officer of G D Searle & Co and President of G D Searle & Co
1999-N/A
Former Director
2001-2014
Former Senior Independent Non-Executive Director, Member of Audit Committee, Member of Ethics & Compliance Committee and Member of Nomination & Governance Committee
2001-Present
Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Finance Committee
2001-Present
Non-Executive Director, Member of Audit Committee and Member of Remuneration Committee
2001-Present
Non-Executive Director
2002-Present
Director
2004-2010
Former Independent Director, Vice Chairman of Governance Committee and Member of Audit Committee
2012-Present
Chairman, Chairman of Compensation Committee and Member of Governance & Nominating Committee

Education*

MS
The University of Arizona
BS
The University of Arizona
Unknown/Other Education
Columbia Business School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$126,000
Total Calculated Compensation$323,648
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $48.70 USD +1.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$749.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Werner Lanthaler MBA,MPAChief Executive Officer
Evotec AG
€601.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.